The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $316.85

Today's change-2.16 -0.68%
Updated September 21 10:46 AM EDT. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $316.85

Today's change-2.16 -0.68%
Updated September 21 10:46 AM EDT. Delayed by at least 15 minutes.

Biogen Inc down (U.S.)$2.16

Biogen Inc is lower today, dropping (U.S.)$2.16 or 0.68% to (U.S.)$316.85. Shares have lost 2.11% over the last five days, but sit 3.99% below their 52-week high. This security has underperformed the S&P 500 by 14.10% during the last year.

Key company metrics

  • Open(U.S.) $316.39
  • Previous close(U.S.) $319.00
  • High(U.S.) $317.96
  • Low(U.S.) $314.44
  • Bid / Ask(U.S.) $316.76 / (U.S.) $317.00
  • YTD % change+11.73%
  • Volume244,113
  • Average volume (10-day)1,251,154
  • Average volume (1-month)1,257,659
  • Average volume (3-month)1,414,260
  • 52-week range(U.S.) $244.28 to (U.S.) $330.00
  • Beta0.77
  • Trailing P/E20.81×
  • P/E 1 year forward14.83×
  • Forward PEG2.19×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $15.23
Updated September 21 10:46 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.21%Sector:HealthcareIndustry:Biotechnology

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue3,0782,8112,8722,956
Total other revenue--------
Total revenue3,0782,8112,8722,956
Gross profit2,7122,4262,4942,539
Total cost of revenue366385379417
Total operating expense1,8781,7861,9861,531
Selling / general / administrative430499496463
Research & development796423534529
Depreciation / amortization118449104100
Interest expense (income), net operating--------
Unusual expense (income)1411046318
Other operating expenses, total2721115
Operating income1,2011,0248861,425
Interest income (expense), net non-operating-64-63-65-66
Gain (loss) on sale of assets--------
Other--------
Income before tax1,1329878381,367
Income after tax8637486481,030
Income tax, total270239190337
Net income8637486491,033
Total adjustments to net income--------
Net income before extra. items8637486491,033
Minority interest0013
Equity in affiliates0000
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8637486491,033
Inc. avail. to common incl. extra. items8637486491,033
Diluted net income8637486491,033
Dilution adjustment--------
Diluted weighted average shares212216217219
Diluted EPS excluding extraordinary itemsvalue per share4.073.462.994.71
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share4.713.504.644.77